Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels

[1]  J. Deckers,et al.  Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease. , 2011, Blood.

[2]  D. Trégouët,et al.  Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels , 2011, Journal of thrombosis and haemostasis : JTH.

[3]  G. Malerba,et al.  Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile. , 2010, Blood.

[4]  S. Heath,et al.  A multi‐stage multi‐design strategy provides strong evidence that the BAI3 locus is associated with early‐onset venous thromboembolism , 2010, Journal of thrombosis and haemostasis : JTH.

[5]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[6]  C. Gieger,et al.  Genetic Regulation of Serum Phytosterol Levels and Risk of Coronary Artery Disease , 2010, Circulation. Cardiovascular genetics.

[7]  Claudio Michelassi,et al.  ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study. , 2010, Atherosclerosis.

[8]  T. Ishizuka,et al.  Promotion of cell spreading and migration by vascular endothelial‐protein tyrosine phosphatase (VE‐PTP) in cooperation with integrins , 2010, Journal of cellular physiology.

[9]  M. Valdés,et al.  Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. , 2010, Thrombosis research.

[10]  Reedik Mägi,et al.  GWAMA: software for genome-wide association meta-analysis , 2010, BMC Bioinformatics.

[11]  A. Hofman,et al.  Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels. , 2010, Human molecular genetics.

[12]  Ming-Huei Chen,et al.  Novel Associations of Multiple Genetic Loci With Plasma Levels of Factor VII, Factor VIII, and von Willebrand Factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium , 2010, Circulation.

[13]  H. Kronenberg,et al.  The transcriptional cofactor Lbh regulates angiogenesis and endochondral bone formation during fetal bone development. , 2009, Developmental biology.

[14]  S. Heath,et al.  Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. , 2009, Blood.

[15]  C. Amos,et al.  Normalizing a large number of quantitative traits using empirical normal quantile transformation , 2007 .

[16]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[17]  D. A. Tregouet,et al.  A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies , 2007, Bioinform..

[18]  C. Mannhalter,et al.  Low‐density lipoprotein receptor‐related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism , 2007, Journal of thrombosis and haemostasis : JTH.

[19]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[20]  D. Benos,et al.  Surface Expression of ASIC2 Inhibits the Amiloride-sensitive Current and Migration of Glioma Cells* , 2006, Journal of Biological Chemistry.

[21]  G. Gellissen,et al.  Defect of vacuolar protein sorting stimulates proteolytic processing of human urokinase-type plasminogen activator in the yeast Hansenula polymorpha. , 2005, FEMS yeast research.

[22]  A. Joyner,et al.  Congenital heart disease reminiscent of partial trisomy 2p syndrome in mice transgenic for the transcription factor Lbh , 2005, Development.

[23]  D. Tregouet,et al.  Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort , 2005, British journal of haematology.

[24]  Alain Favier,et al.  The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. , 2004, Archives of internal medicine.

[25]  A. Folsom,et al.  Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.

[26]  J. Danesh,et al.  von Willebrand factor and coronary heart disease: prospective study and meta-analysis. , 2002, European heart journal.

[27]  Mary Sara McPeek,et al.  Enhanced Pedigree Error Detection , 2002, Human Heredity.

[28]  L R Cardon,et al.  The power to detect linkage disequilibrium with quantitative traits in selected samples. , 2001, American journal of human genetics.

[29]  L. Almasy,et al.  Genetic determinants of hemostasis phenotypes in Spanish families. , 2000, Circulation.

[30]  A. Folsom,et al.  Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1999, Circulation.

[31]  T. Stevens,et al.  The VPS8 gene is required for localization and trafficking of the CPY sorting receptor in Saccharomyces cerevisiae. , 1996, European journal of cell biology.

[32]  J. Vandenbroucke,et al.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.

[33]  Wj Gauderman,et al.  QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies , 2006 .

[34]  P. Reitsma,et al.  High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism , 2000, Thrombosis and Haemostasis.